NGX stocks
146 listed companies · Fundamental profile from official NGX filings.
AGRICULTURECONGLOMERATESCONSTRUCTION/REAL ESTATECONSUMER GOODSFINANCIAL SERVICESHEALTHCAREICTINDUSTRIAL GOODSINVESTMENTNATURAL RESOURCESOIL AND GASSERVICESUTILITIES
7 of 146 companies match · prices as of 2026-11-18 · ratios 2 days old
| Company | Signal | Market cap | P/E | P/B | ROE | Dividend yield | Price | FY |
|---|---|---|---|---|---|---|---|---|
MECUREMeCure Industries | Fairly valued | ₦225bn | 34.7× | 11.3× | 32.6% | 0.57% | ₦56.20 | 2025 |
FIDSONFidson Healthcare | Expensive | ₦275bn | 36.4× | 11.6× | 24.4% | — | ₦91.80 | 2024 |
NEIMETHNeimeth International Pharma | Expensive | ₦35bn | 30.9× | 13.2× | 37.2% | — | ₦7.10 | 2025 |
MORISONMorison Industries | Expensive | ₦13bn | 1,040.0× | 10.9× | 1.0% | — | ₦10.40 | 2025 |
EKOCORPEkocorp Plc | Expensive | ₦3bn | — | — | — | — | ₦5.79 | 2020 |
MAYBAKERMay & Baker Nigeria | Expensive | ₦69bn | — | — | — | — | ₦40.00 | 2025 |
PHARMDEKOPharma-Deko Plc | Expensive | ₦0bn | — | — | — | — | ₦1.83 | — |
▶Advanced filters
Signal score uses justified P/E (Damodaran model), ROE vs cost of equity, and company-specific risk. Ratios use each company's latest annual report that passed arithmetic checks. Dividend yield counts cash dividends with an ex-date in the last 12 months. Hover a figure to see notes. This is data, not advice.